ResMed Total Long-Term Assets 2010-2024 | RMD

ResMed total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • ResMed total long-term assets for the quarter ending September 30, 2024 were $4.581B, a 3.27% increase year-over-year.
  • ResMed total long-term assets for 2024 were $4.515B, a 2.98% increase from 2023.
  • ResMed total long-term assets for 2023 were $4.384B, a 38.54% increase from 2022.
  • ResMed total long-term assets for 2022 were $3.164B, a 0.35% increase from 2021.
ResMed Annual Total Long-Term Assets
(Millions of US $)
2024 $4,515
2023 $4,384
2022 $3,164
2021 $3,153
2020 $3,064
2019 $2,962
2018 $1,998
2017 $1,824
2016 $1,837
2015 $774
2014 $805
2013 $762
2012 $777
2011 $776
2010 $641
2009 $655
ResMed Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $4,581
2024-06-30 $4,515
2024-03-31 $4,463
2023-12-31 $4,527
2023-09-30 $4,436
2023-06-30 $4,384
2023-03-31 $4,376
2022-12-31 $4,351
2022-09-30 $3,144
2022-06-30 $3,164
2022-03-31 $3,201
2021-12-31 $3,188
2021-09-30 $3,143
2021-06-30 $3,153
2021-03-31 $3,120
2020-12-31 $3,121
2020-09-30 $3,078
2020-06-30 $3,064
2020-03-31 $3,041
2019-12-31 $3,053
2019-09-30 $2,993
2019-06-30 $2,962
2019-03-31 $2,996
2018-12-31 $2,796
2018-09-30 $1,979
2018-06-30 $1,998
2018-03-31 $1,930
2017-12-31 $1,810
2017-09-30 $1,832
2017-06-30 $1,824
2017-03-31 $1,817
2016-12-31 $1,802
2016-09-30 $1,847
2016-06-30 $1,837
2016-03-31 $1,045
2015-12-31 $888
2015-09-30 $722
2015-06-30 $774
2015-03-31 $725
2014-12-31 $768
2014-09-30 $775
2014-06-30 $805
2014-03-31 $801
2013-12-31 $781
2013-09-30 $777
2013-06-30 $762
2013-03-31 $795
2012-12-31 $801
2012-09-30 $794
2012-06-30 $777
2012-03-31 $803
2011-12-31 $795
2011-09-30 $792
2011-06-30 $776
2011-03-31 $760
2010-12-31 $739
2010-09-30 $724
2010-06-30 $641
2010-03-31 $683
2009-12-31 $694
2009-09-30 $680
2009-06-30 $655
2009-03-31 $598
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.759B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.382B 25.94
Stryker (SYK) United States $148.728B 33.52
Boston Scientific (BSX) United States $134.855B 38.77
EssilorLuxottica (ESLOY) France $111.549B 0.00
Medtronic (MDT) Ireland $108.676B 16.14
Haleon (HLN) United Kingdom $43.230B 28.09
Lonza Group Ag (LZAGY) Switzerland $42.368B 0.00
GE HealthCare Technologies (GEHC) United States $37.464B 19.43
Terumo (TRUMY) Japan $29.367B 41.47
Koninklijke Philips (PHG) Netherlands $24.796B 18.98
Zimmer Biomet Holdings (ZBH) United States $21.580B 13.74
Insulet (PODD) United States $18.378B 73.18
Baxter (BAX) United States $16.844B 10.96
Smith & Nephew SNATS (SNN) United Kingdom $10.947B 0.00
BellRing Brands (BRBR) United States $9.886B 39.63
Bio-Rad Laboratories (BIO) United States $9.115B 30.98
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.071B 14.11
TG Therapeutics (TGTX) United States $5.378B 0.00
Haemonetics (HAE) United States $4.291B 20.94
Prestige Consumer Healthcare (PBH) United States $4.157B 20.67
ICU Medical (ICUI) United States $4.134B 39.36
Perrigo (PRGO) Ireland $3.694B 10.88
Envista Holdings (NVST) United States $3.681B 27.42
Agios Pharmaceuticals (AGIO) United States $3.167B 0.00
Neogen (NEOG) United States $3.159B 36.45
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.782B 17.84
QuidelOrtho (QDEL) United States $2.548B 16.40
LeMaitre Vascular (LMAT) United States $2.380B 57.85
Warby Parker (WRBY) United States $2.366B 0.00
Green Thumb Industries (GTBIF) United States $1.977B 34.59
AtriCure (ATRC) United States $1.740B 0.00
InMode (INMD) Israel $1.552B 9.34
AdaptHealth (AHCO) United States $1.331B 9.51
Curaleaf Holdings (CURLF) Canada $1.293B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.253B 0.00
BioLife Solutions (BLFS) United States $1.178B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.97
Owens & Minor (OMI) United States $0.943B 7.37
National Vision Holdings (EYE) United States $0.910B 30.40
CeriBell (CBLL) United States $0.904B 0.00
Evolus (EOLS) United States $0.826B 0.00
Capricor Therapeutics (CAPR) United States $0.809B 0.00
VAREX IMAGING (VREX) United States $0.679B 30.02
Surmodics (SRDX) United States $0.561B 0.00
Cresco Labs (CRLBF) United States $0.561B 0.00
Verano Holdings (VRNOF) United States $0.554B 0.00
Quanterix (QTRX) United States $0.450B 0.00
Omeros (OMER) United States $0.448B 0.00
Canopy Growth (CGC) Canada $0.407B 0.00
ZimVie (ZIMV) United States $0.379B 31.95
Valneva SE (VALN) France $0.359B 0.00
Viemed Healthcare (VMD) United States $0.339B 32.26
Biote (BTMD) United States $0.334B 7.31
Sanara MedTech (SMTI) United States $0.326B 0.00
Cerus (CERS) United States $0.310B 0.00
OraSure Technologies (OSUR) United States $0.287B 19.25
Zynex (ZYXI) United States $0.258B 54.07
Aurora Cannabis (ACB) Canada $0.236B 0.00
TerrAscend (TSNDF) Canada $0.224B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.12
High Tide (HITI) Canada $0.215B 89.00
MacroGenics (MGNX) United States $0.201B 0.00
Sanuwave Health (SNWV) United States $0.189B 2.67
Jin Medical (ZJYL) China $0.166B 0.00
Organigram Holdings (OGI) Canada $0.164B 0.00
Brainsway (BWAY) Israel $0.164B 98.40
Zevia PBC (ZVIA) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.147B 18.50
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Fonar (FONR) United States $0.104B 11.75
Quipt Home Medical (QIPT) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.10
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.079B 0.00
Rockwell Medical (RMTI) United States $0.071B 36.67
Exagen (XGN) United States $0.069B 0.00
Modular Medical (MODD) United States $0.067B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.061B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.053B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Cytosorbents (CTSO) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00